register

News & Trends - MedTech & Diagnostics

Workforce challenges force hospital group acquisition

Health Industry Hub | December 14, 2022 |

MedTech News: With hospitals at large struggling to retain staff following the pandemic, healthcare companies like Healius have had to reevaluate their portfolio and cut their losses.

Four years after acquiring Montserrat Day Hospitals, Healius has decided to let go of them. Healius acquired Montserrat in 2018 for $122 million.

The company entered into a binding agreement to sell Montserrat Day Hospitals, an operator of 11 specialist short-stay hospitals and haematology/oncology clinics to Nexus Hospitals, which also operates short-stay and day hospitals, for an enterprise value of up to $138.6 million.

Healius’ Managing Director and Chief Executive Officer, Dr Malcolm Parmenter, stated “The sale of Montserrat is in-line with our strategy to focus on the growth of our diagnostics businesses. The proceeds of the sale will enable us to strengthen our balance sheet during this transition period as we reset our cost base and operating model for the post-pandemic era and, over time, deploy capital in growth opportunities.”

Nexus Hospitals is controlled by funds managed by the Queensland Investment Corporation (QIC). It operates hospitals peppered across the country, primarily providing specialist day and short-stay hospitals. Together with Montserrat Day, Nexus Hospitals will operate a portfolio of 29 short-stay hospitals across Australia underpinned by over 700 surgeons, thus creating the largest short-stay hospital platform in the country.

CEO of Nexus Hospitals, Andrew Petering, commented “Montserrat’s strong patient focus aligns well with Nexus Hospitals’ core values. We look forward to the scale and depth that the combined businesses will provide for our patients and the overall Australian healthcare system through the ongoing delivery of affordable healthcare services with excellent clinical outcomes and patient experiences.”

That’s not all the associations the company is forming with Nexus. In a bid to secure renewable energy for its sustainability initiatives, it is also in discussions with QIC regarding participation in the latter’s upcoming green power purchase agreement process. If successful, Healius expects to benefit from QIC’s larger scale to access more attractive terms.

The Montserrat Day transaction is set to settle by June 2023, with Healius’s new CEO Maxine Jaquet taking over following Parmenter’s resignation.

Healius will continue to provide pathology services across a number of existing Montserrat facilities with the potential to expand the provision of diagnostic services with Nexus Hospitals.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


Human Resources

Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day

Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day

Health Industry Hub | May 20, 2024 |

People & Culture: Coinciding with International HR Day, Karen Newell, Senior HR Director for ANZ at Medtronic, joined Health Industry […]

More


News & Trends - MedTech & Diagnostics

Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation

Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation

Health Industry Hub | May 20, 2024 |

MedTech & Diagnostics News: An Australian-based medtech company announced promising results from the first-in-human study for its pulsed field ablation […]

More


News & Trends - MedTech & Diagnostics

Federal budget delivers 'mixed news' for radiologists

Federal budget delivers ‘mixed news’ for radiologists

Health Industry Hub | May 20, 2024 |

MedTech & Diagnostics News: The Royal College of Australian and New Zealand Radiologists (RANZCR) and the Interventional Radiology Society of […]

More


News & Trends - Pharmaceuticals

AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers

AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers

Health Industry Hub | May 20, 2024 |

Pharma News: The Senate Community Affairs References Committee has released its inquiry report into Equitable access to diagnosis and treatment […]

More


This content is copyright protected. Please subscribe to gain access.